Lixte Biotechnology Holdings earnings were -$3.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest LIXT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$617.7k, down 37.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LIXT reported annual earnings of -$3.6M, with -29.5% growth. The next LIXT earnings date is May 7, 2025.
Lixte Biotechnology Holdings Earnings Reports & History FAQ
What were Lixte Biotechnology Holdings's earnings last quarter?
On LIXT's earnings call on Invalid Date, Lixte Biotechnology Holdings (NASDAQ: LIXT) reported Q4 2024 earnings per share (EPS) of -$0.27, up 34.15% year over year. Total LIXT earnings for the quarter were -$617.69 thousand. In the same quarter last year, Lixte Biotechnology Holdings's earnings per share (EPS) was -$0.41.
When does Lixte Biotechnology Holdings report earnings?
The next LIXT earnings date is Invalid Date. Add LIXT to your watchlist to be reminded of Lixte Biotechnology Holdings's next earnings date.
What was LIXT's earnings growth in the past year?
As of Lixte Biotechnology Holdings's earnings date in Invalid Date, Lixte Biotechnology Holdings's earnings has grown year over year. LIXT earnings in the past year totalled -$3.59 million.
Is Lixte Biotechnology Holdings profitable or losing money?
As of the last Lixte Biotechnology Holdings earnings report, Lixte Biotechnology Holdings is currently losing money. Lixte Biotechnology Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$3.59 million, a 29.51% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.